Macrogenics (MGNX) Other Operating Expenses (2021 - 2026)

Macrogenics (MGNX) has 6 years of Other Operating Expenses data on file, last reported at $9.5 million in Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $9.5 million, up 76.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $40.1 million (up 157.59% YoY), and the FY2025 annual result was $36.0 million, up 192.78% from the prior year.
• Other Operating Expenses slipped to $9.5 million in Q1 2026 per MGNX's latest filing, from $10.1 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $11.6 million in Q3 2025 and troughed at $48000.0 in Q1 2022.
• A 5-year average of $4.3 million and a median of $3.1 million in 2022 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2022 and 2023: Other Operating Expenses jumped 10818.18% in 2022, then tumbled 90.9% in 2023.
• A 5-year view of Other Operating Expenses shows it stood at $1.8 million in 2022, then plunged by 90.9% to $163000.0 in 2023, then soared by 3268.1% to $5.5 million in 2024, then soared by 84.24% to $10.1 million in 2025, then decreased by 5.78% to $9.5 million in 2026.
• Business Quant data shows MGNX's Other Operating Expenses at $9.5 million in Q1 2026, $10.1 million in Q4 2025, and $11.6 million in Q3 2025.